Instructions Induced Prescribing Physicians to Infringe
In Eli Lilly and Company v. Teva Parenteral Medicines, Inc., [2015-2067] (January 12, 2017), the Federal Circuit affirmed judgment of inducement of infringement of U.S. Patent No. 7,772,209, and that the the asserted claims were not invalid for indefiniteness, obviousness, or obviousness-type double patenting. … Continue reading Instructions Induced Prescribing Physicians to Infringe
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed